upstreambio.com (UPB) - Final Profit

UPB (Upstream Bio, Inc.) - company brandmark

This chart illustrates the price trend reflecting the profit dynamics of Upstream Bio Inc (UPB), which stands at -0.16. Upstream Bio Inc (UPB) is laying the foundation for pricing power through verekitumab, which effectively suppresses inflammatory processes in severe asthma. The business model relies on outsourcing production and testing, while crisis resilience is ensured by an autonomous innovation development cycle.

UPB Upstream Bio Inc Company Net Income (10/12/2024 - 10/29/2026)

Comprehensive metric breakdowns and analytics for Upstream Bio (UPB)

- market value and analyst target forecast:
Stock Price Upstream Pharma|UPB - Consensus Target
- market capitalization indicators:
Market Value Upstream Pharma|UPB - Enterprise Value
- business book valuation details:
Net Assets per Share Upstream Bio|UPB - Company Book Value|Market Cap to Net Assets Ratio upstreambio.com|UPB - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Upstream Bio Inc|UPB - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Upstream Bio, Inc.|UPB - Company Debts|Debt to Book Value Ratio Upstream Pharma|UPB - Company Long-Term Debts|Short-Term Debt Upstream Bio|Quick Ratio upstreambio.com
- earnings and multiples data:
UPB - Company Net Income
Basic company analysis:Upstream Pharma
Core merchandise of Upstream Bio

Upstream Bio Inc (UPB) combines the development of anti-inflammatory drugs with high-tech cold chain logistics. Net income measures the final financial result after deducting all operating expenses and taxes. The trend in the organization's net income reflects the efficiency of debt management and resilience to macro shocks. Stable growth confirms the profitability of diversified laboratories and the reliability of supply chains. This asset falls into the category of high-risk biotechnological investments.

Direct competitors

argenx BVBA (ARGX) - Net Profit|Net Income BNTX|ABVX: Final Profit|Net Profit ADMA|Net Financial Result Protagonist Therapeutics, Inc.|Company Net Income Immunovant Corp IMVT|KNSA - Net Income|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|CLDX (Celldex Therapeutics, Inc.) - Net Income|Aurinia Pharmaceuticals Inc (AUPH) - Net Profit|Company Net Income BioCryst Pharmaceuticals Inc|Company Profit VERA (Vera Corp)|Net Profit DNTH|PHVS - Company Net Income|AbCellera Biologics Inc - Net Income|Net Profit Tourmaline Bio Inc TRML|PGEN - Company Net Income|Profit After Tax PHAR|Nektar Therapeutics (NKTR) - Company Net Income|ZBIO - Net Financial Result|Net Income IMNM|GOSS (Gossamer Bio Inc) - Profit After Payment of Taxes|Company Net Income KalVista Pharmaceuticals Inc (KALV)|SEPN (Septerna Pharma) - Final Profit|Net Profit PVLA (Pieris Pharmaceuticals)|savarapharma.com (SVRA) - Company Net Income|Rigel Pharmaceuticals, Inc. - Net Profit|ANAB - Net Profit|Astria Pharma (ATXS) - Company Net Income|Net Income enGene Corp|Net Income RAPT|JBIO: Final Profit|Net Profit ACRS|Company Net Income KYTX (Kyverna Therapeutics Inc.)|Net Profit TLSA (Tiziana Life Sciences PLC)|Net Financial Result Cabaletta Bio Inc (CABA)|VTYX - Company Net Income|Company Net Income theratech.com|AVTX (Avalo Therapeutics) - Net Income|Eledon Pharmaceuticals Inc. - Final Profit|AGEN (Agenus Inc) - Net Profit|Climb Bio, Inc (CLYM) - Net Financial Result|Company Net Income Zura Bio Limited (ZURA)|atyrpharma.com - Company Profit|Net Profit ADAG (Adagene Inc.)|IMA - Net Income|STTK: Net Income|EQ - Net Profit|connectbiopharm.com (CNTB) - Company Net Income|Profit After Tax IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|Company Net Income IFRX|Company Net Income X4 Pharma (XFOR)|ACET: Profit After Tax|Net Profit CELU (Celularity)|Final Profit INMB|Barinthus Biotherapeutics plc - Net Profit|KZR - Net Profit|SAB Biotherapeutics, Inc (SABS) - Company Net Income|Akari Therapeutics, Plc - Final Profit|Company Net Income Enlivex Therapeutics Ltd|Net Income Q32 Bio Corp (QTTB)|Net Profit GOVX|Net Profit Edesa Biotech Inc (EDSA)|iBio Corp - Net Income|Final Profit CARM|XTL Biopharmaceuticals - Net Profit|Net Financial Result Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Company Net Income|Net Income Aptevo Therapeutics Inc.|Company Net Income AIM ImmunoTech|Net Income Aditxt Corp (ADTX)|Net Income GRI (GRI Bio, Inc.)|Net Profit xortx.com (XRTX)|Company Net Income Vyome Holdings HIND|REVB: Company Profit|Indaptus - Net Profit|Company Net Income BiondVax Pharmaceuticals|CALI (calcimedica.com) - Net Income|Affimed N.V. (AFMD) - Net Profit|Company Net Income Allakos Inc|HOOKIPA - Profit After Tax|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Financial Result iTeos Pharma|Ocean Biomedical, Inc. - Net Income|Profit After Payment of Taxes TCBP (tcbiopharm.com)|THRD - Company Net Income